151 related articles for article (PubMed ID: 34633646)
1. Direct Oral Anticoagulants and Warfarin for Atrial Fibrillation Treatment: Rural and Urban Trends in Medicare Beneficiaries.
Norby FL; Lutsey PL; Shippee ND; Chen LY; Henning-Smith C; Alonso A; Walker RF; Folsom AR
Am J Cardiovasc Drugs; 2022 Mar; 22(2):207-217. PubMed ID: 34633646
[TBL] [Abstract][Full Text] [Related]
2. Race/Ethnicity and Sex-Related Differences in Direct Oral Anticoagulant Initiation in Newly Diagnosed Atrial Fibrillation: A Retrospective Study of Medicare Data.
Essien UR; Magnani JW; Chen N; Gellad WF; Fine MJ; Hernandez I
J Natl Med Assoc; 2020 Feb; 112(1):103-108. PubMed ID: 32035755
[TBL] [Abstract][Full Text] [Related]
3. Latent Classes of Adherence to Oral Anticoagulation Therapy Among Patients With a New Diagnosis of Atrial Fibrillation.
Chen N; Brooks MM; Hernandez I
JAMA Netw Open; 2020 Feb; 3(2):e1921357. PubMed ID: 32074287
[TBL] [Abstract][Full Text] [Related]
4. Population Dementia Incidence and Direct Oral Anticoagulant Use in a Representative Population With Atrial Fibrillation.
Thunell J; Wood K; Wharton W; Joyce G; Ferido P; Zissimopoulos J
Neurology; 2024 Jul; 103(1):e209568. PubMed ID: 38857466
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Oral Anticoagulant Use and Stroke Risk Among Older Adults Newly-Diagnosed Atrial Fibrillation Living in Urban-Versus-Rural Areas.
Guo J; He M; Magnani JW; Brooks MM; Gellad WF; Hernandez I
Am J Cardiol; 2020 Sep; 130():64-69. PubMed ID: 32680675
[TBL] [Abstract][Full Text] [Related]
6. Trends in Use of Oral Anticoagulants in Older Adults With Newly Diagnosed Atrial Fibrillation, 2010-2020.
Ko D; Lin KJ; Bessette LG; Lee SB; Walkey AJ; Cheng S; Kim E; Glynn RJ; Kim DH
JAMA Netw Open; 2022 Nov; 5(11):e2242964. PubMed ID: 36399339
[TBL] [Abstract][Full Text] [Related]
7. Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010-2016.
Ardeshirrouhanifard S; An H; Goyal RK; Raji MA; Segal JB; Alexander GC; Mehta HB
Pharmacotherapy; 2022 May; 42(5):375-386. PubMed ID: 35364622
[TBL] [Abstract][Full Text] [Related]
8. Comparing total medical expenditure between patients receiving direct oral anticoagulants vs warfarin for the treatment of atrial fibrillation: evidence from VA-Medicare dual enrollees.
Wong ES; Done N; Zhao M; Woolley AB; Prentice JC; Mull HJ
J Manag Care Spec Pharm; 2021 Aug; 27(8):1056-1066. PubMed ID: 34337995
[No Abstract] [Full Text] [Related]
9. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
10. Trends in utilization of warfarin and direct oral anticoagulants in older adult patients with atrial fibrillation.
Alalwan AA; Voils SA; Hartzema AG
Am J Health Syst Pharm; 2017 Aug; 74(16):1237-1244. PubMed ID: 28652320
[TBL] [Abstract][Full Text] [Related]
11. Association of Race and Ethnicity and Anticoagulation in Patients With Atrial Fibrillation Dually Enrolled in Veterans Health Administration and Medicare: Effects of Medicare Part D on Prescribing Disparities.
Essien UR; Kim N; Magnani JW; Good CB; Litam TMA; Hausmann LRM; Mor MK; Gellad WF; Fine MJ
Circ Cardiovasc Qual Outcomes; 2022 Feb; 15(2):e008389. PubMed ID: 34779655
[TBL] [Abstract][Full Text] [Related]
12. Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries.
Wheelock KM; Ross JS; Murugiah K; Lin Z; Krumholz HM; Khera R
JAMA Netw Open; 2021 Dec; 4(12):e2137288. PubMed ID: 34870678
[TBL] [Abstract][Full Text] [Related]
13. Prescribing Patterns of Direct-Acting Oral Anticoagulants in Patients With Atrial Fibrillation and Chronic Kidney Disease: A Retrospective Cohort Analysis.
Reyes JL; Herzog CA; Yan H; Roetker NS; Wetmore JB
J Cardiovasc Pharmacol Ther; 2022; 27():10742484221142220. PubMed ID: 36472155
[TBL] [Abstract][Full Text] [Related]
14. Influence of Direct Oral Anticoagulants on Rates of Oral Anticoagulation for Atrial Fibrillation.
Marzec LN; Wang J; Shah ND; Chan PS; Ting HH; Gosch KL; Hsu JC; Maddox TM
J Am Coll Cardiol; 2017 May; 69(20):2475-2484. PubMed ID: 28521884
[TBL] [Abstract][Full Text] [Related]
15. Trends in Oral Anticoagulant Use Among 436 864 Patients With Atrial Fibrillation in Community Practice, 2011 to 2020.
Navar AM; Kolkailah AA; Overton R; Shah NP; Rousseau JF; Flaker GC; Pignone MP; Peterson ED
J Am Heart Assoc; 2022 Nov; 11(22):e026723. PubMed ID: 36346063
[TBL] [Abstract][Full Text] [Related]
16. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
Carnicelli AP; Hong H; Connolly SJ; Eikelboom J; Giugliano RP; Morrow DA; Patel MR; Wallentin L; Alexander JH; Cecilia Bahit M; Benz AP; Bohula EA; Chao TF; Dyal L; Ezekowitz M; A A Fox K; Gencer B; Halperin JL; Hijazi Z; Hohnloser SH; Hua K; Hylek E; Toda Kato E; Kuder J; Lopes RD; Mahaffey KW; Oldgren J; Piccini JP; Ruff CT; Steffel J; Wojdyla D; Granger CB;
Circulation; 2022 Jan; 145(4):242-255. PubMed ID: 34985309
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends in the Use and Comparative Effectiveness of Direct Oral Anticoagulant Agents Versus Warfarin for Nonvalvular Atrial Fibrillation: A Canadian Population-Based Study.
Yu AYX; Malo S; Svenson LW; Wilton SB; Hill MD
J Am Heart Assoc; 2017 Oct; 6(11):. PubMed ID: 29080863
[TBL] [Abstract][Full Text] [Related]
18. Switching warfarin to direct oral anticoagulants in atrial fibrillation: Insights from the NCDR PINNACLE registry.
Sciria CT; Maddox TM; Marzec L; Rodwin B; Virani SS; Annapureddy A; Freeman JV; O'Hare A; Liu Y; Song Y; Doros G; Zheng Y; Lee JJ; Daggubati R; Vadlamani L; Cannon C; Desai NR
Clin Cardiol; 2020 Jul; 43(7):743-751. PubMed ID: 32378265
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease.
Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS
Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001
[TBL] [Abstract][Full Text] [Related]
20. Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
Lutsey PL; Norby FL; Ensrud KE; MacLehose RF; Diem SJ; Chen LY; Alonso A
JAMA Intern Med; 2020 Feb; 180(2):245-253. PubMed ID: 31764956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
